Category Archives: Global
Lilly's Decentralized Global Launch Strategy
Global headquarters may get the strategic ball rolling for a new drug launch, but Lilly’s affiliates are responsible for bringing home the bacon, according to a Lilly global brand director.
Tiered Pricing Not Always a Win-Win
Tiered pricing, or selling critical medicines to developing countries at a standardized discount price, can improve access in the short term, but arbitrary demographic groupings and misaligned incentives often stack the deck in favor of manufacturers, not patients.
Also posted in Corporate Responsibility, Emerging Markets, IP, Manufacturing, Market Access, R&D, Strategy, pricing 2 Comments
The Seven-Billion Society: What's In It For Pharma?
On Monday, the world’s population hit the 7 billion mark, repeating a pattern of largely unrestrained growth that has endured for the last century: the world is now adding roughly one billion people every 12 years. The UN Population Fund (UNPF) estimates that, barring some unforeseen demographic or environmental/development shifts, the figure will reach just [...]
Also posted in Op-Ed, healthcare Tagged Big Pharma, healthcare, innovation, population, UN 1 Comment

Arise Sir Andrew (Witty)